Loading organizations...
§ Private Profile · Jiading, Shanghai, China
Provider of cellular diagnosis, research, and treatment services.
Shanghai Cell Therapy Group has raised $210.8M across 2 funding rounds.
Shanghai Cell Therapy Group has raised $210.8M in total across 2 funding rounds.
Shanghai Cell Therapy Group has raised $210.8M across 2 funding rounds. Most recently, it raised $76.7M Series D in March 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 24, 2021 | $76.7M Series D | — | CCB International, Haier Capital, Jiuzhou Venture | Announced |
| Dec 17, 2018 | $134.1M Series C | China Industrial Asset Management, Haier Capital | Anting People's Government, Legend Capital, Ningbo Yuanhui | Announced |
Shanghai Cell Therapy Group has raised $210.8M in total across 2 funding rounds.
Shanghai Cell Therapy Group's investors include CCB International, Haier Capital, Jiuzhou Venture, China Industrial Asset Management, Anting People's Government, Legend Capital, Ningbo Yuanhui.